Predict your next investment

FINANCIAL | Insurance / Property & Casualty

See what CB Insights has to offer

Stage

Other Investors | Alive

About Aix

AIX Group, Inc. is a property and casualty insurance holding company with executive offices in Windsor, CT, that aims to provide services through its wholly owned subsidiaries: Nova Casualty Company, an A- rated property and casualty insurance company that is licensed in all 50 states, and AIX Specialty Insurance Company, a non-admitted company domiciled in Delaware.

Aix Headquarter Location

Latest Aix News

Nationale 1: Montluçon must forget its Aix and “focus” on Annecy

Nov 20, 2021

Recovered from his painful breakup in Aix, the Blanzat Sport Montluçon (Allier) seems ready to start a new story … Indeed, after the slap of last week at the Union Paix d’Aix-Bouc (36-22), in National 1 female, the girls of the BSM (7th ex aequo, 16 pts) do not intend to turn the other cheek. […] The post Nationale 1: Montluçon must forget its Aix and “focus” on Annecy appeared first on Archyworldys.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aix Patents

Aix has filed 4 patents.

The 3 most popular patent topics include:

  • Cannabinoids
  • Cellular respiration
  • Experimental cancer drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/10/2016

11/17/2020

Cellular respiration, Cannabinoids, Experimental cancer drugs, Monoclonal antibodies, Metabolism

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/10/2016

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/17/2020

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cellular respiration, Cannabinoids, Experimental cancer drugs, Monoclonal antibodies, Metabolism

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.